Want to see HK:0570 full AI Analyst Report?
0570 Stock Chart & Stats
HK$1.41
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$1.41
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.32 - HK$2.68
Previous CloseN/A
Volume9.79M
Average Volume (3M)51.13M
Market Cap
HK$7.20B
Enterprise ValueHK$10.41K
Total Cash (Recent Filing)HK$5.16B
Total Debt (Recent Filing)HK$2.49B
Price to Earnings (P/E)―
Beta0.42
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)-0.07
Shares Outstanding5,035,802,000
10 Day Avg. Volume46,853,920
30 Day Avg. Volume51,130,115
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.46
Price to Sales (P/S)0.64
P/FCF Ratio4.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.14
Revenue Forecast (FY)HK$14.38B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA conservative capital structure with falling total debt and improving leverage reduces refinancing risk and preserves financial flexibility. This supports the company’s ability to fund operations, weather industry cycles, and invest selectively without immediate external financing.
Strong Recent Cash GenerationRobust operating and free cash flow in 2024–2025 indicates the business still converts sales into liquidity. Durable cash generation can fund dividends, working capital and deleveraging, providing a buffer while management addresses profitability drivers.
Healthy Gross ProfitSustained gross profit implies underlying product economics and pricing retain strength. If operating costs and SG&A are controlled, gross-margin resilience offers a pathway back to overall profitability as volumes stabilize or cost programs take effect.
Bears Say
Profitability DeteriorationThe shift to a net loss by 2025 materially reduces return on equity and the company's internal ability to compound capital. Persistent losses strain retained earnings, limit reinvestment capacity and make dividend and growth strategies harder to sustain without a clear earnings recovery.
Inconsistent & Declining RevenueRepeated revenue downturns and negative multi-year growth undermine predictability of cash flows and scale economics. Structural weakness in demand or pricing reduces margin leverage and increases execution risk for any turnaround or investment plans.
Volatile Cash Flow And FCF DeclineHistorical FCF volatility and a recent sharp slowdown in FCF growth indicate working-capital swings or one-off pressures. That volatility raises concern about the sustainability of dividends, capital spending and whether cash conversion will support recovery plans long-term.
China Traditional Chinese Medicine Holdings Co News
0570 FAQ
What was China Traditional Chinese Medicine Holdings Co Ltd’s price range in the past 12 months?
China Traditional Chinese Medicine Holdings Co Ltd lowest stock price was HK$1.32 and its highest was HK$2.68 in the past 12 months.
What is China Traditional Chinese Medicine Holdings Co Ltd’s market cap?
China Traditional Chinese Medicine Holdings Co Ltd’s market cap is HK$7.20B.
When is China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date?
China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 26 days.
How were China Traditional Chinese Medicine Holdings Co Ltd’s earnings last quarter?
China Traditional Chinese Medicine Holdings Co Ltd released its earnings results on Mar 20, 2026. The company reported -HK$0.051 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is China Traditional Chinese Medicine Holdings Co Ltd overvalued?
According to Wall Street analysts China Traditional Chinese Medicine Holdings Co Ltd’s price is currently Overvalued.
Does China Traditional Chinese Medicine Holdings Co Ltd pay dividends?
China Traditional Chinese Medicine Holdings Co Ltd pays a Notavailable dividend of HK$0.086 which represents an annual dividend yield of 0.24%. See more information on China Traditional Chinese Medicine Holdings Co Ltd dividends here
What is China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate?
China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Traditional Chinese Medicine Holdings Co Ltd have?
China Traditional Chinese Medicine Holdings Co Ltd has 5,035,802,000 shares outstanding.
What happened to China Traditional Chinese Medicine Holdings Co Ltd’s price movement after its last earnings report?
China Traditional Chinese Medicine Holdings Co Ltd reported an EPS of -HK$0.051 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.529%.
Which hedge fund is a major shareholder of China Traditional Chinese Medicine Holdings Co Ltd?
Currently, no hedge funds are holding shares in HK:0570
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Traditional Chinese Medicine Holdings Co Ltd
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
Technical Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Wai Yuen Tong Medicine Holdings Limited
―
Grand Pharmaceutical Group Limited
―
Golden Throat Holdings Group Co Ltd
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―